multiple sclerosis

The FDA has approved alemtuzumab (Lemtrada) as a treatment for patients with multiple sclerosis. The FDA was careful to cite that use of alemtuzumab was a high-risk… Read More »Alemtuzumab Approved For Multiple Sclerosis